Find stats on top websites
Axonics External Trial System
Axonics Sacral Neuromodulation System
Axonics Sacral Neuromodulation MRI Device
Axonics' key value proposition is providing a 'TRULY Recharge-Free SNM System' that offers long-term, effective relief from bladder and bowel dysfunction. This innovation significantly improves patient convenience and quality of life by eliminating the need for frequent device recharging.
Axonics positions itself as the leader in patient-friendly Sacral Neuromodulation, offering the only truly recharge-free SNM system for bladder and bowel dysfunction. They empower patients with lasting relief and improved quality of life.
Medtronic InterStim
Boston Scientific (broader urology solutions)
Nevro Corp.
Customer sentiment appears to be positive and hopeful, as patients are actively seeking effective, long-term solutions after failed traditional treatments. They are motivated to engage and qualify for Axonics' advanced therapy, indicating a high level of trust and interest.
To reinforce its brand position, Axonics should continue emphasizing the 'truly recharge-free' benefit in all patient-facing communications and leverage patient testimonials showcasing sustained relief.
The Axonics® External Trial System is a diagnostic and preliminary assessment tool designed to allow healthcare providers to evaluate the effectiveness of sacral neuromodulation (SNM) therapy for patients experiencing urinary or bowel dysfunction. This system enables patients to trial the therapy externally, without undergoing a full surgical implant, to assess symptom improvement before committing to the permanent procedure. It facilitates a reversible and non-invasive initial assessment, providing valuable insights into potential patient response to SNM.
Axonics® System is an FDA-approved, clinically proven Sacral Neuromodulation solution for the treatment of urinary and bowel dysfunction.
View sourceJan 8, 2024 ... Axonics Reports Preliminary 4Q23 and Fiscal Year 2023 Revenue. https://ir.axonics.com/news-releases. SOURCE Boston Scientific Corporation.
View sourceAxonics SNM Systems deliver constant current stimulation to help maintain the right amount of therapy and reduce the need for patients to make adjustments.
View sourceInvestors · Recent Quarterly Results · Boston Scientific Conference Call Discussing Second Quarter Financial Results · Annual Results and Proxy Statements.
View sourceSign up now and unleash the power of AI for your business growth